Published Jul 10, 2026, 5:27 PM ET · Updated 4 months ago · 1 source
Shionogi-Backed Apnimed Files for IPO to Fund Sleep Apnea Drug
bloomberg
·
Original Report
Apnimed Inc. filed for a US initial public offering, as its oral drug to treat obstructive sleep apnea moves closer to being commercialized.